McKesson Corp (MCK) stock
MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3026% above fair value
$1102.81+25.76 (+2.39%)
Close on Nov 13, 2026Market cap $128.58BP/E 28.4Yield 0.29%
McKesson total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
McKesson's total debt was $9.21B at Sep 30, 2026. For fiscal 2026 it was $6.53B, up 15.4% from the year before. Over ten years it grew -2.2% a year on average. The highest annual figure on record is $10.59B in fiscal 2014.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $6.53B | +15.4% |
| FY2025 | Mar 31, 2025 | $5.65B | +0.4% |
| FY2024 | Mar 31, 2024 | $5.63B | +0.6% |
| FY2023 | Mar 31, 2023 | $5.59B | -4.8% |
| FY2022 | Mar 31, 2022 | $5.88B | -17.8% |
| FY2021 | Mar 31, 2021 | $7.15B | -3.2% |
| FY2020 | Mar 31, 2020 | $7.39B | -2.7% |
| FY2019 | Mar 31, 2019 | $7.60B | -3.6% |
| FY2018 | Mar 31, 2018 | $7.88B | -7.8% |
| FY2017 | Mar 31, 2017 | $8.55B | +5.3% |
| FY2016 | Mar 31, 2016 | $8.11B | -17.6% |
| FY2015 | Mar 31, 2015 | $9.84B | -7.1% |
| FY2014 | Mar 31, 2014 | $10.59B | +117.4% |
| FY2013 | Mar 31, 2013 | $4.87B | +36.1% |
| FY2012 | Mar 31, 2012 | $3.58B | -10.6% |
| FY2011 | Mar 31, 2011 | $4.00B | +74.4% |
| FY2010 | Mar 31, 2010 | $2.30B | -8.5% |
| FY2009 | Mar 31, 2009 | $2.51B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 30, 2026 | $9.21B | +18.7% |
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $9.73B | +25.1% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $6.53B | +15.4% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $6.56B | -18.2% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $7.76B | +35.1% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $7.78B | +38.0% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $5.65B | +0.4% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $8.01B | +36.0% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $5.74B | +2.9% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $5.64B | -0.5% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $5.63B | +0.6% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $5.89B | -9.0% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $5.58B | -0.5% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $5.66B | -2.0% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $5.59B | -4.8% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $6.47B | +2.3% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $5.61B | -6.2% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $5.78B | -19.5% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $5.88B | -17.8% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $6.33B | -14.4% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $5.99B | -21.3% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $7.18B | -3.7% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $7.15B | -3.2% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $7.40B | -24.9% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $7.61B | -7.1% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $7.45B | -3.2% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $7.39B | -2.7% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $9.85B | +0.7% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $8.19B | -9.8% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $7.69B | -21.1% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $7.60B | -3.6% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $9.78B | +11.3% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $9.09B | +9.2% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $9.75B | +22.6% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $7.88B | -7.8% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $8.79B | -3.6% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $8.32B | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $7.95B | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $8.55B | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $9.12B | – |
See a number that looks wrong?